Author: News Room
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Edwards between February 6, 2024 and July 24, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [Click here to submit your transactions] NEW YORK, Nov. 02, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edwards Lifesciences Corporation (“Edwards” or the…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Elanco To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Elanco between November 7, 2023 and June 26, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [Click here to submit your transactions] NEW YORK, Nov. 02, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elanco Animal Health Incorporated (“Elanco” or…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Bumble To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Bumble between November 7, 2023 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [Click here to submit your transactions] NEW YORK, Nov. 02, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bumble Inc. (“Bumble” or the “Company”)…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Allarity To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Allarity between May 17, 2022 and July 19, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [Click here to submit your transactions] NEW YORK, Nov. 02, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Allarity Therapeutics, Inc. (“Allarity” or the…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Agenus To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Agenus between January 23, 2023 and July 17, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [Click here to submit your transactions] NEW YORK, Nov. 02, 2024 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Agenus Inc. (“Agenus” or the “Company”)…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Webtoon To Contact Him Directly To Discuss Their Options If you suffered losses in Webtoon pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with Webtoon’s initial public offering conducted on or about June 27, 2024 (the “IPO” or “Offering”)and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [Click here to submit your transactions] NEW YORK, Nov. 02, 2024 (GLOBE NEWSWIRE)…
New York, NY, Nov. 01, 2024 (GLOBE NEWSWIRE) — In a series of highly impactful talks and panels over the past few weeks, Dr. Anna Yusim, a globally recognized psychiatrist, Clinical Assistant Professor at Yale University, and Chief Medical Officer of Conscious Health, led various discussions aimed at transforming the future of mental health care. She did this across multiple prestigious platforms, including three panels at the United Nations General Assembly (UNGA) Science Summit, a keynote at the Conscious Leaders Summit as part of NYC Climate Week, participation at a panel on Mindful Innovation and Entrepreneurship at the Bhutan Innovation Forum, a keynote at the Healthspan Summit, and a presentation on…
Palo Alto, CA, Nov. 01, 2024 (GLOBE NEWSWIRE) — Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced U.S. Centers for Medicare & Medicaid Services (CMS) have granted the company’s Paradise® Ultrasound Renal Denervation system a Transitional Pass-through (TPT) payment. The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years. In approving the TPT, CMS created a distinct device category and code (C1736: Catheter…
DELAND, Florida, Nov. 01, 2024 (GLOBE NEWSWIRE) — A new poll conducted by Stetson University’s Center for Public Opinion Research (CPOR) shows former President Donald Trump with a notable lead over Vice President Kamala Harris among likely Florida voters. The survey, conducted between Oct. 25 and Nov. 1, reveals Trump ahead by 7 points, securing support from 53% of likely voters compared to 46% for Harris. The poll surveyed 452 likely voters, with results weighted by age, ethnicity, race, gender, education, party affiliation and geography to reflect the state’s historical voting patterns. The survey has a credibility interval of +/-…
Salt Lake City, UT, Nov. 01, 2024 (GLOBE NEWSWIRE) — Vinesign by Filevine, a leader in electronic signature technology, today announced the launch of its new Public API designed to enhance business efficiency and productivity by allowing seamless integration of its e-signature solutions into existing digital ecosystems. With this innovative API, businesses can now effortlessly connect Vinesign with their Customer Relationship Management (CRM) systems and other tools via web automations, facilitating the automated sending of documents or templates for signature. The introduction of Vinesign’s Public API marks a significant advancement in how businesses manage and execute digital transactions. By providing…